Advinus Therapeutics and P2D Bioscience Enter Into a Research and Development Collaboration for Attention Deficit Hyperactivity Disorder (ADHD)

Advinus Therapeutics Ltd., a drug discovery and development company, and P2D Bioscience, a CNS-focused specialty pharmaceutical company, have initiated a research and development collaboration to develop therapies for Attention Deficit Hyperactivity Disorder (ADHD). Visit P2Dinc.com to learn more. Tweet

TeamDynamix Adds Asset Management, People Database to Leading Project, Portfolio and Service Desk Management Software

TeamDynamix has released version 8.1 of its web-based project, portfolio and service desk management solution. Among hundreds of new and enhanced features, this latest release adds asset management to complement the tool’s robust project and ticket management capabilities. Created specifically for the needs of higher education,TeamDynamixHE enables colleges and universities to prioritize work, quickly adapt to […]